TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: CGM standard deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CGM coefficient of variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TB Disease-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in emotional functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Effectiveness of outpatient treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Safety of outpatient treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Change in children's social-emotional development, behaviour and self-regulation skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in children's executive functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in educator's teaching practices and classroom quality
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Validity of FQoR-15 questionnaire (24 hours)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Validity of FQoR-15 questionnaire (48 hours)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prognosis of cerebral hemorrhage at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Changes in the coronary sinus blood flow spectrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in left ventricular diastolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of SAEs after each dose of MVA-BN vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of SAEs after each dose of MVA-BN vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of AEs after each dose of MVA-BN vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of AEs after each dose of MVA-BN vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Patients Stratified as High/Imminent Risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients Admitted to Inpatient Psychiatric Treatment
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Emergency Department Psychiatric Boarding Hours for Admitted Patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: volume of sweat produced during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colonization of microorganisms involved in Atopic Dermatitis flares-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Assessment of cutaneous hydratation in Atopic Dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Assessment of skin barrier condition in Atopic Dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Non-Hospitalized Participants
Endpoint domain: Mortality/survival
Primary endpoint: Number of Hospitalized Participants Requiring Supplemental Oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Hospitalized Participants Requiring High-flow Oxygen Therapy or Noninvasive Mechanical Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Major cytogenetic response (MCyR) rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Quantitive change in intestinal microbiota in stool samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitive change in endocannabinoids levels in blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitive change in inflammation biomarker in blood samples - C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rate of closure failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Identify burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Identify any self-reported stressors associated with burnout
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of resolution of severe pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Bereavement Experience Questionnaire (BEQ-24)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall distribution of progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Median percentage change in the overall number of countable observable seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Systemic inflammatory status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Device rate of safety
Endpoint domain: Adverse events/effects
Primary endpoint: Muscle Atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bilirubin levels in newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants Who Experienced a Wound Complication
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Whose Wound Surface Area Decreased
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Overall Quality of Life: ASCQ-Me Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Stroke Aphasic Depression Questionnaire-10 (SADQ-10)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Behavioural Outcomes of Anxiety scale (BOA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anterior tongue pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior tongue pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right buccal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left buccal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Labial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of UFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in Mean Increase in Daily Oral Feeding Volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics similarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of agreement in screening results (Cohen's Kappa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trajectories and prevalence or incidence of patient-reported outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improvement of lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hippocampus total volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insula total volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol diurnal excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Primary cognitive efficacy endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Comfort and Patient acceptance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: blood pressure systolic and diastolic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Corneal endothelial cell changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores for both knees
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Visual analogous scale score for knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in genital sensitivity pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of undetectable Minimal Residual Disease (uMRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity during walking on visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity during standing on visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity during sitting position on visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: white blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: inflammatory markers in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood alcohol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Empathy Quotient
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety as a trait
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants Who Developed Symptomatic SARS-CoV-2 Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Mean awake ambulatory systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Behavioral difficulties
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with the diagnosis NSTE-ACS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of subjects at risk for aspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects at low risk for aspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of confirmed SLE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Parent-child communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Parents' worries
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Parental Self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Infant gut microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Regional lung volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ratio of 48-Week to Baseline Neutralizing Antibody Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Preliminary efficacy in terms of within-group average change in general anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preliminary efficacy in terms of within-group average change in depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preliminary efficacy in terms of within-group improvement in health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Identification of microchimeric cells of maternal origin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quantification of microchimeric cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Correlation between breastfeeding status and microchimeric cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worse pain occurrence during first 24 hours after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants reporting use of resources
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Clinical Global Impression scale - Severity (CGI-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SRAE Scores - Middle School
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SRAE Scores - High School
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Requirement for permanent pacemaker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Conditioned pain modulation (CPM) magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SpO2 Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quantitative Oxygen Consumption Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: severity of premenstrual syndrome symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the number of medication recommendations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: early traumatic brain injury-related death in the hospital
Endpoint domain: Mortality/survival
Primary endpoint: Intracranial haemorrhage growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-surgical pain at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year invasive disease free survival rate (iDFS)
Endpoint domain: Mortality/survival
Primary endpoint: Pain-associated inflammatory factor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dosage of analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in anti-Mullerian hormone (AMH), estradiol and FSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in testosterone, inhibin B, SHBG and FSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Timed Up And Go Test (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tetrax (Computerized Static Posturography Device)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Positive and Negative Affect Schedule (PANAS-SF) performance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Immediate Word Recall performance from the Rey Auditory Verbal Learning Task (RAVLT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Corsi Block Tapping Test (CBTT) performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: DOSE-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with normal overall coronal alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications of the underlying disease
Endpoint domain: Adverse events/effects
Primary endpoint: Indicators of gut permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Disease Control Rate after 24 weeks of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes fMRI signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Item memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Context memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Affect memory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depression severity measured by HDRS-17
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perception of usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective effectiveness of eNutrition Optimizer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Relative change in the number of inflammatory lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success defined by improvement in mIGA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the Hamilton Depression Rating Scale (HAM-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in the Montgomery-Åsberg Depression Rating Scale (MADRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in the Global Assessment of Functioning (GAF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Subjective rating of sound processor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health related Quality of Life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Participant willingness
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diagnosis accuracy of temporomandibular joint disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frenchay activities index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: adverse events of grade ≥ 2
Endpoint domain: Adverse events/effects
Primary endpoint: Number of wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pulse value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saturation value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower burden of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Family's prediction accuracy of patient's treatment preferences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Status of kalaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lumbar extension range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of lateral flexion range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy in miniscrews direct placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-operator variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-operator variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified modified Schober test for assessment of lumbar flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Diadochokinetic (DDK) rate of alternating and sequential labial, alveolar and velar plosive sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tongue strength endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mastication efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants who Achieve a Psoriasis Area and Severity Index (PASI) 90 Response at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants who Achieve an Investigator's Global Assessment (IGA) Score of Cleared (0) or Minimal (1) at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuron-specific enolase (NSE) Blood Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurotensin Blood Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall antibiotic prescribing rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Post-surgery recovery quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cerebrospinal fluid (CSF) biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Physical Activity Level (Light physical activity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity Level (Moderate-to-vigorous physical activity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity Level (Daily step count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of percutaneous surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of appropriate interpreter use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient Health Questionnaire for Teens (PHQ-A)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Word form recall accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Word meaning recall accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning